Shilanski & Associates’s Solventum SOLV Stock Holding History

Shilanski & Associates’s Portfolio SOLV Stock Details SOLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5,515	Closed	-$292K	–	126
2024 Q2	$292K	Buy	+5,515	New	+$335K	0.1%	76

Other funds holding SOLV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TFM

Trian Fund Management New York $4.23B AUM 31.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Shilanski & Associates's SOLV Position: Q3 2024 in Review

Shilanski & Associates sold out of Solventum (SOLV) in Q3 2024, closing a stake of 5,515 shares — an estimated $292K sold.

Shilanski & Associates first reported a position in SOLV in Q2 2024 and held it in 1 quarter. The position peaked at $292K in Q2 2024. 938 funds tracked by Wall St. Rank hold SOLV as of Q3 2024.

Shilanski & Associates reported no remaining Solventum position as of Q3 2024 after selling out during the quarter.
Shilanski & Associates sold 5,515 Solventum shares in Q3 2024, an estimated $292K.
Shilanski & Associates first reported a position in Solventum in Q2 2024 and held it in 1 quarter.
Shilanski & Associates's Solventum position peaked at $292K in Q2 2024.
938 funds tracked by Wall St. Rank held Solventum as of Q3 2024.

Based on Shilanski & Associates's 13F filing for Q3 2024, filed 12 Nov 2024.